In a significant development, OpenEvidence, an AI-powered medical information platform, has achieved a $12 billion valuation following a recent Series D funding round. The startup secured an additional $250 million in funding, co-led by Thrive Capital and DST, marking a substantial increase from its previous $6 billion valuation in October.
OpenEvidence’s growth underscores the increasing importance of AI in transforming healthcare information accessibility. Positioned as a platform for medical professionals, the company competes with similar services like Anthropic’s Claude for Healthcare and ChatGPT’s consumer-focused health product.
Despite facing competition, OpenEvidence reported serving 18 million clinical consultations in the U.S. in December, a significant surge from its previous metrics. The platform’s success is further exemplified by surpassing $100 million in revenue, showcasing its impact on the healthcare industry.
This milestone signals the broader trend of AI integration in medical information platforms. As tech companies leverage AI to enhance healthcare services, the industry is witnessing a shift towards advanced data-driven solutions for medical professionals and patients.
Source: TechCrunch